Cargando…

Multivesicular Liposomes for Glucose-Responsive Insulin Delivery

An intelligent insulin delivery system is highly desirable for diabetes management. Herein, we developed a novel glucose-responsive multivesicular liposome (MVL) for self-regulated insulin delivery using the double emulsion method. Glucose-responsive MVLs could effectively regulate insulin release i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guangqu, He, Suping, Ding, Yu, Chen, Cai, Cai, Qingchun, Zhou, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781467/
https://www.ncbi.nlm.nih.gov/pubmed/35056918
http://dx.doi.org/10.3390/pharmaceutics14010021
_version_ 1784638093346734080
author Liu, Guangqu
He, Suping
Ding, Yu
Chen, Cai
Cai, Qingchun
Zhou, Wei
author_facet Liu, Guangqu
He, Suping
Ding, Yu
Chen, Cai
Cai, Qingchun
Zhou, Wei
author_sort Liu, Guangqu
collection PubMed
description An intelligent insulin delivery system is highly desirable for diabetes management. Herein, we developed a novel glucose-responsive multivesicular liposome (MVL) for self-regulated insulin delivery using the double emulsion method. Glucose-responsive MVLs could effectively regulate insulin release in response to fluctuating glucose concentrations in vitro. Notably, in situ released glucose oxidase catalyzed glucose enrichment on the MVL surface, based on the combination of (3-fluoro-4-((octyloxy)carbonyl)phenyl)boronic acid and glucose. The outer MVL membrane was destroyed when triggered by the local acidic and H(2)O(2)-enriched microenvironment induced by glucose oxidase catalysis in situ, followed by the further release of entrapped insulin. Moreover, the Alizarin red probe and molecular docking were used to clarify the glucose-responsive mechanism of MVLs. Utilizing chemically induced type 1 diabetic rats, we demonstrated that the glucose-responsive MVLs could effectively regulate blood glucose levels within a normal range. Our findings suggest that glucose-responsive MVLs with good biocompatibility may have promising applications in diabetes treatment.
format Online
Article
Text
id pubmed-8781467
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87814672022-01-22 Multivesicular Liposomes for Glucose-Responsive Insulin Delivery Liu, Guangqu He, Suping Ding, Yu Chen, Cai Cai, Qingchun Zhou, Wei Pharmaceutics Article An intelligent insulin delivery system is highly desirable for diabetes management. Herein, we developed a novel glucose-responsive multivesicular liposome (MVL) for self-regulated insulin delivery using the double emulsion method. Glucose-responsive MVLs could effectively regulate insulin release in response to fluctuating glucose concentrations in vitro. Notably, in situ released glucose oxidase catalyzed glucose enrichment on the MVL surface, based on the combination of (3-fluoro-4-((octyloxy)carbonyl)phenyl)boronic acid and glucose. The outer MVL membrane was destroyed when triggered by the local acidic and H(2)O(2)-enriched microenvironment induced by glucose oxidase catalysis in situ, followed by the further release of entrapped insulin. Moreover, the Alizarin red probe and molecular docking were used to clarify the glucose-responsive mechanism of MVLs. Utilizing chemically induced type 1 diabetic rats, we demonstrated that the glucose-responsive MVLs could effectively regulate blood glucose levels within a normal range. Our findings suggest that glucose-responsive MVLs with good biocompatibility may have promising applications in diabetes treatment. MDPI 2021-12-22 /pmc/articles/PMC8781467/ /pubmed/35056918 http://dx.doi.org/10.3390/pharmaceutics14010021 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liu, Guangqu
He, Suping
Ding, Yu
Chen, Cai
Cai, Qingchun
Zhou, Wei
Multivesicular Liposomes for Glucose-Responsive Insulin Delivery
title Multivesicular Liposomes for Glucose-Responsive Insulin Delivery
title_full Multivesicular Liposomes for Glucose-Responsive Insulin Delivery
title_fullStr Multivesicular Liposomes for Glucose-Responsive Insulin Delivery
title_full_unstemmed Multivesicular Liposomes for Glucose-Responsive Insulin Delivery
title_short Multivesicular Liposomes for Glucose-Responsive Insulin Delivery
title_sort multivesicular liposomes for glucose-responsive insulin delivery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781467/
https://www.ncbi.nlm.nih.gov/pubmed/35056918
http://dx.doi.org/10.3390/pharmaceutics14010021
work_keys_str_mv AT liuguangqu multivesicularliposomesforglucoseresponsiveinsulindelivery
AT hesuping multivesicularliposomesforglucoseresponsiveinsulindelivery
AT dingyu multivesicularliposomesforglucoseresponsiveinsulindelivery
AT chencai multivesicularliposomesforglucoseresponsiveinsulindelivery
AT caiqingchun multivesicularliposomesforglucoseresponsiveinsulindelivery
AT zhouwei multivesicularliposomesforglucoseresponsiveinsulindelivery